Healthcare fund managers caution against getting caught up in Covid-19 vaccine hype
Gilead Sciences has taken investors on a rollercoaster ride as it trials a treatment for the coronavirus
Gilead Sciences has taken investors on a rollercoaster ride as it trials a treatment for the coronavirus
|
|
‘When we could not prove that remote working could work, people were afraid to try it’
|
|
Five investors mull the events shaping portfolios over the past week
|
|
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
|
|
Portfolio Adviser looks at the tomes keeping investors informed and entertained during the Covid-19 outbreak
|
|
Charles Stanley among investment firms leading the way with volunteer force of staff and clients
|
|
Middle of the month saw buying frenzy as evidence showed pandemic outbreak was slowing
|
|
Premier Diversified Growth manager hedged two-thirds of the portfolio before it became expensive to do so
|
|
FTSE 100 companies spent £136bn buying back their own shares from 2010 to 2019
|
|
Woodford Equity Income liquidation and virus create stumbling blocks to gearing reduction and portfolio rebalancing
|
|
The key events for UK wealth managers for the week starting 4 May
|
|
Five investors mull the events shaping portfolios over the past week
|
|